Noxopharm Limited (NOX.AX)
AUD 0.09
(-1.06%)
AUD 0.09
(-1.06%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -2.31 Million AUD | 22.89% |
| 2023 | -3 Million AUD | 78.28% |
| 2022 | -13.85 Million AUD | 47.63% |
| 2021 | -26.44 Million AUD | -1159.3% |
| 2020 | -2.1 Million AUD | -305.73% |
| 2019 | 1.02 Million AUD | 110.94% |
| 2018 | -9.33 Million AUD | -279.77% |
| 2017 | -2.45 Million AUD | 60.21% |
| 2016 | -6.17 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -5.15 Million AUD | 0.0% |
| 2024 Q4 | -2.31 Million AUD | 0.0% |
| 2024 FY | -2.31 Million AUD | 22.89% |
| 2023 FY | -3 Million AUD | 78.28% |
| 2023 Q2 | -11.1 Million AUD | 0.0% |
| 2023 Q4 | -3 Million AUD | 0.0% |
| 2022 Q2 | -16.4 Million AUD | 0.0% |
| 2022 FY | -13.85 Million AUD | 47.63% |
| 2022 Q4 | -13.85 Million AUD | 0.0% |
| 2021 Q2 | -18.48 Million AUD | 0.0% |
| 2021 FY | -26.44 Million AUD | -1159.3% |
| 2021 Q4 | -26.44 Million AUD | 0.0% |
| 2020 FY | -2.1 Million AUD | -305.73% |
| 2020 Q4 | -2.1 Million AUD | 0.0% |
| 2020 Q2 | 5.81 Million AUD | 0.0% |
| 2019 Q2 | -6 Million AUD | 0.0% |
| 2019 Q4 | 1.02 Million AUD | 0.0% |
| 2019 FY | 1.02 Million AUD | 110.94% |
| 2018 Q4 | -9.33 Million AUD | 0.0% |
| 2018 FY | -9.33 Million AUD | -279.77% |
| 2018 Q2 | -3.98 Million AUD | 0.0% |
| 2017 Q2 | -4.33 Million AUD | 0.0% |
| 2017 FY | -2.45 Million AUD | 60.21% |
| 2017 Q4 | -2.45 Million AUD | 0.0% |
| 2016 FY | -6.17 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | -18.89 Million AUD | 87.724% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -136.219% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 145.782% |
| Biome Australia Limited | -1.56 Million AUD | -48.446% |
| Patrys Limited | -2.24 Million AUD | -3.538% |
| Orthocell Limited | -19.92 Million AUD | 88.357% |
| Imugene Limited | -91.56 Million AUD | 97.466% |
| PYC Therapeutics Limited | -65.76 Million AUD | 96.472% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | 24.012% |
| Prescient Therapeutics Limited | -10.16 Million AUD | 77.172% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | 63.315% |
| Cynata Therapeutics Limited | -6.2 Million AUD | 62.614% |
| CSL Limited | 15.76 Billion AUD | 100.015% |
| Arovella Therapeutics Limited | -12.71 Million AUD | 81.754% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -226.954% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 98.732% |
| Starpharma Holdings Limited | -19.83 Million AUD | 88.302% |
| Nanollose Limited | -96.22 Thousand AUD | -2310.94% |
| Memphasys Limited | 4.13 Million AUD | 156.1% |
| Invex Therapeutics Ltd | -6.02 Million AUD | 61.495% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | 53.172% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -27.218% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 97.075% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -87.331% |
| Race Oncology Limited | -17.18 Million AUD | 86.503% |
| Nyrada Inc. | -4.76 Million AUD | 51.358% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 97.807% |
| Dimerix Limited | -21.99 Million AUD | 89.451% |
| PharmAust Limited | -9.71 Million AUD | 76.118% |
| Immutep Limited | -122.18 Million AUD | 98.101% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 98.3% |
| Alterity Therapeutics Limited | -12.47 Million AUD | 81.411% |
| BTC Health Limited | -2.02 Million AUD | -14.725% |
| Acrux Limited | -1.45 Million AUD | -59.117% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | 86.428% |
| Biotron Limited | -386.06 Thousand AUD | -500.911% |
| Tissue Repair Ltd | -16.44 Million AUD | 85.889% |
| AdAlta Limited | -845.17 Thousand AUD | -174.491% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | 87.511% |
| Hexima Limited | -2.22 Million AUD | -4.21% |
| AnteoTech Limited | -5 Million AUD | 53.616% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | 86.805% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | 31.689% |
| Avecho Biotechnology Limited | -5.32 Million AUD | 56.468% |
| Actinogen Medical Limited | -9.13 Million AUD | 74.595% |
| Immuron Limited | -11.48 Million AUD | 79.798% |
| Argenica Therapeutics Limited | -15.91 Million AUD | 85.421% |